The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk

Clinical trial NCT05152888 · RECRUITING

Trial details

NCT number: NCT05152888
Sponsor: Brigham and Women's Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Stable Coronary Disease

Start date: 2022-03-03
Primary completion: 2027-03-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.